Skip to main content

Pentraxins and Atherosclerosis: The Role of PTX3

Buy Article:

$68.00 + tax (Refund Policy)

Pentraxins are a family of evolutionarily conserved multifunctional pattern-recognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver in response to IL-6, while PTX3 is produced by a variety of tissues and cells and in particular by innate immunity cells in response to proinflammatory signals and Toll-like receptor (TLR) engagement. PTX3 interacts with several ligands, including growth factors, extracellular matrix components and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes, acting as a predecessor of antibodies. In addition, PTX3 is essential in female fertility by acting as a nodal point for the assembly of the cumulus oophorus hyaluronanrich extracellular matrix. Here we will concisely review the general properties of PTX3 in the context of the pentraxin superfamily and discuss recent data suggesting that PTX3 plays a cardiovascular protective effect. PTX3 may represent a new marker in vascular pathology which correlates with the risk of developing vascular events.





Keywords: Astragalus bisculatus; Balkan Endemic Nephropathy; Bioavailability; Bronchial asthma; Coumarin; Kashin-Beck Syndrome; Keshan Disease (KD); Lymphedema; Nephropathy; PTX3; Pentraxin; Phleum pratense L; Prepartum supplementation; Se cruciferae; Se-cysteine; Se-dependent deiodinases; Se-methionine; Selenomax; Selenomethionine (Semet); Selenoprotein P; White Muscle Disease (WMD); antagonism; atherosclerosis; bio-fortification; flavon-oids; forages; glutathione peroxidase; goiter; inflammation; innate immunity; iodine deiodinase; leek (Allium porrum); methylselenocysteine (SeMCYS); myo-degenerative syndrome; pedogenesis; red clover (Trifolium pratense L; ryegrass; selenifer-ous regions; seleniferous soils; selenoproteins; selenotrisulfide; sesquioxides; severe sepsis; sulfur fertilization; tocopherol; unthriftyness; urinary tract tumors; vascular pathology

Document Type: Research Article

Publication date: 01 January 2011

More about this publication?
  • Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

    Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content